DrugPatentWatch Database Preview
Methylprednisolone - Generic Drug Details
» See Plans and Pricing
What are the generic sources for methylprednisolone and what is the scope of patent protection?
Methylprednisolone
is the generic ingredient in eleven branded drugs marketed by Pfizer, Duramed Pharms Barr, Heather, Invatech, Jubilant Cadista, Lupin Ltd, Novast Labs, Par Pharm, Sandoz, Sungen Pharma, Tianjin Tianyao, Vintage Pharms, Watson Labs, Zydus Pharms, Pharmacia And Upjohn, Bel Mar, Akorn, Amneal, Sagent Pharms Inc, Sandoz Inc, Teva Pharms Usa, Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, and Teva Parenteral, and is included in eighty-five NDAs. Additional information is available in the individual branded drug profile pages.There are forty drug master file entries for methylprednisolone. Thirty suppliers are listed for this compound.
Summary for methylprednisolone
| US Patents: | 0 |
| Tradenames: | 11 |
| Applicants: | 33 |
| NDAs: | 85 |
| Drug Master File Entries: | 40 |
| Suppliers / Packagers: | 30 |
| Bulk Api Vendors: | 83 |
| Clinical Trials: | 606 |
| Patent Applications: | 7,146 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for methylprednisolone |
| Drug Sales Revenues: | Drug sales revenues for methylprednisolone |
| What excipients (inactive ingredients) are in methylprednisolone? | methylprednisolone excipients list |
| DailyMed Link: | methylprednisolone at DailyMed |
Recent Clinical Trials for methylprednisolone
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| The Geneva Foundation | N/A |
| United States Department of Defense | N/A |
| Johns Hopkins University | N/A |
Pharmacology for methylprednisolone
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for methylprednisolone
US Patents and Regulatory Information for methylprednisolone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius Kabi Usa | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040612-001 | Aug 12, 2004 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Pharmacia And Upjohn | MEDROL ACETATE | methylprednisolone acetate | OINTMENT;TOPICAL | 012421-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Jubilant Cadista | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 040189-003 | Jul 20, 2007 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Lupin Ltd | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 209097-002 | Feb 22, 2019 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Sungen Pharma | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 212262-001 | Jun 27, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2021 - 2022
NCE-1 Patent Challenge Dates 2021 - 2022
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2021, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
